Comirnaty LP.8.1 30 Mikrogramm, Injektionsdispersion in einer Fertigspritze
7680704030010
CH-70403
Mikrogramm
Associated product:
COMIRNATY LP.8.1 30 Mikrogramm sol inj 30 µg 1 pce
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Mikrogramm
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
COVID-19 mRNA LP.8.1
|
30.0 UG | Substance | Wirkstoff (Principe actif) |
|
((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diylis)bis(2-hexyldecanoas)
|
- | Substance | HNIDK |
|
2-(polyethylenglycoli 2000)-N,N-ditetradecylacetamidum
|
- | Substance | HNIDK |
|
1,2-distearoyl-sn-glycero-3-phosphocholinum
|
- | Substance | HNIDK |
|
cholesterolum
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
trometamolum
|
- | Substance | HNIDK |
|
trometamoli hydrochloridum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 70403
- Drug name
- Comirnaty LP.8.1, Injektionsdispersion in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- J07BN01
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 06/08/2025
- Authorization expiration date
- 05/08/2030
- IT Number
- 08.08.
- Domain
- Human medicine
Package details
- Description (FR)
- COMIRNATY LP.8.1 30 Mikrogramm sol inj 30 µg 1 pce
- Description (DE)
- COMIRNATY LP.8.1 30 Mikrogramm Inj Lös 30 µg 1 Stk
- Market launch
- 06/08/2025
- Narcotic (BTM)
- No
Other package sizes (1)
COMIRNATY LP.8.1 30 Mikrogramm sol inj 30 µg 10 pc
10 FESP
GTIN: 7680704030027